ClinicalTrials.Veeva

Menu

Cognoa Autism Spectrum Disorder (ASD) Digital Therapeutic Engagement and Usability Study

C

Cognoa

Status

Terminated

Conditions

Autism Spectrum Disorder

Treatments

Device: Usability assessment of Cognoa ASD Therapeutic Device

Study type

Interventional

Funder types

Industry

Identifiers

NCT04326231
PRO-003

Details and patient eligibility

About

Cognoa will measure usability, engagement with the device, and changes in parent-reported socialization during a 4-week period of intervention at home with the Cognoa ASD therapeutic device.

Full description

Parents who consent will be given access to the study device through its caregiver and child-facing smartphone app that provides therapeutic content. In order to access the study device app, parents will be provided access to two other apps. The first is Testflight. TestFlight is an online service for over-the-air installation and testing of mobile applications, currently owned by Apple Inc.that allows users to test iOS apps before they are released to the App Store. Parents will also be provided access to the Cognoa for Child Development app in order to create an account as a means to gain access to the study device app. The parents will only be able to engage with the study device app once they have created an account in the Cognoa for Child for Development app

Enrollment

10 patients

Sex

All

Ages

3 to 8 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Functional English language capability in the home environment.
  • Parent, Guardian, or legal authorized representative (LAR) must be able to read, understand and sign the Informed Consent Form (ICF)
  • Female or Male, > 3 to < 9 years of age and parent/caregiver
  • Diagnosis of Autism Spectrum Disorder, within the last 12 months
  • Parent, Guardian, or legal authorized representative (LAR) must have smartphone capabilities for downloading Testflight software; test versions of the Cognoa for Child development app; and test versions of the Cognoa Digital Therapeutic app (iOS 12.0 and up and Apple iPhone 8 and higher)

Exclusion criteria

  • Participants with any other medical, behavioral, or developmental condition that in the opinion of the investigator may confound study data/assessments.
  • Participants with planned extensive travel (more than 1 week) during the course of the 4 week intervention time period.
  • Participants with deafness or blindness.
  • Participants with known physical impairments affecting their ability to use their hands.
  • Participants with active diagnosis of epilepsy and uncontrolled seizures.
  • Participants whose age on the date of enrollment is outside the target age range

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Cognoa ASD Therapeutic Device
Experimental group
Description:
Usability assessment of Cognoa ASD Therapeutic Device
Treatment:
Device: Usability assessment of Cognoa ASD Therapeutic Device

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Kelley Abrams, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems